Search details
1.
A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease.
Cell
; 187(6): 1363-1373.e12, 2024 Mar 14.
Article
in English
| MEDLINE | ID: mdl-38366591
2.
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection.
Cell
; 186(11): 2392-2409.e21, 2023 05 25.
Article
in English
| MEDLINE | ID: mdl-37164012
3.
IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines.
Nat Immunol
; 23(4): 532-542, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35332327
4.
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer.
Immunity
; 2024 May 10.
Article
in English
| MEDLINE | ID: mdl-38749447
5.
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.
Nature
; 618(7963): 144-150, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37165196
6.
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants.
Nature
; 596(7871): 273-275, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34111888
7.
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.
Nature
; 595(7868): 572-577, 2021 07.
Article
in English
| MEDLINE | ID: mdl-34044428
8.
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
N Engl J Med
; 388(3): 214-227, 2023 01 19.
Article
in English
| MEDLINE | ID: mdl-36652353
9.
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
N Engl J Med
; 388(7): 621-634, 2023 02 16.
Article
in English
| MEDLINE | ID: mdl-36791162
10.
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
Nature
; 586(7830): 589-593, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32785213
11.
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Nature
; 586(7830): 594-599, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32998157
12.
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.
Nature
; 585(7823): 107-112, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32728218
13.
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
N Engl J Med
; 386(20): 1910-1921, 2022 05 19.
Article
in English
| MEDLINE | ID: mdl-35320659
14.
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
N Engl J Med
; 386(1): 35-46, 2022 01 06.
Article
in English
| MEDLINE | ID: mdl-34752019
15.
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
N Engl J Med
; 385(3): 239-250, 2021 07 15.
Article
in English
| MEDLINE | ID: mdl-34043894
16.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
N Engl J Med
; 385(19): 1761-1773, 2021 11 04.
Article
in English
| MEDLINE | ID: mdl-34525277
17.
Effect of anti-claudin 18.2 monoclonal antibody zolbetuximab alone or combined with chemotherapy or programmed cell death-1 blockade in syngeneic and xenograft gastric cancer models.
J Pharmacol Sci
; 155(3): 84-93, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38797537
18.
A trans-amplifying RNA simplified to essential elements is highly replicative and robustly immunogenic in mice.
Mol Ther
; 31(6): 1636-1646, 2023 06 07.
Article
in English
| MEDLINE | ID: mdl-36694464
19.
Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection.
Mol Ther
; 31(2): 374-386, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-36303436
20.
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds.
Clin Infect Dis
; 2023 Nov 28.
Article
in English
| MEDLINE | ID: mdl-38016021